Clinical research studyRespiratory Impairment in Older Persons: When Less Means More
Section snippets
Study Population
We used data from the Cardiovascular Health Study (CHS) after obtaining institutional review board approval. The CHS is a population-based, longitudinal study of 5888 Americans aged 65 to 100 years, assembled in 1989 and 1990 as a random sample of Medicare beneficiaries.32, 33
For the present study, eligible participants were white and aged 65 to 80 years, and completed at least 2 acceptable spirometric maneuvers at baseline, as defined by the American Thoracic Society (ATS).34, 35 Our analyses
Results
As shown in Table 1, the mean age was 71.5 years and the mean body mass index was 26.3 kg/m2; 57.7% (2066/3583) were female and 55.9% (2002/3583) were ever-smokers. The mean number of chronic conditions was 1.0, and 20.4% (732/3583) had fair-to-poor health status. Respiratory symptoms were reported by 43.6% (1561/3583), and moderate-to-severe dyspnea was reported by 10.2% (365/3583). A slow gait speed was recorded in 38.5% (1378/3583).
Table 2 shows frequency distributions of participants
Discussion
In a representative population of older persons, we found that twice as many participants are given a designation of respiratory impairment using the GOLD versus LMS, with approximately one half versus one quarter of participants, respectively, classified as abnormal. Subsequent analyses revealed that the GOLD results in overdiagnosis according to clinically based assessments. For example, among asymptomatic never-smokers, the GOLD was 4-fold more likely than LMS to assign a ādiseasedā
Conclusions
Among older persons and on the basis of respiratory symptoms and mobility, respiratory impairment is more clinically meaningful when defined by LMS compared with the GOLD. As 2 potential āless-is-moreā benefits of adopting the LMS approach, both the designation of respiratory impairment in asymptomatic individuals and the unnecessary use of medications for (āfalse positiveā) respiratory disease could be reduced.
References (56)
- et al.
Prevalence and correlates of respiratory symptoms and disease in the elderly
Chest
(1994) - et al.
Frailty and respiratory impairment in older persons
Am J Med
(2012) - et al.
Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey
Am J Med
(2005) - et al.
Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions
Respir Med
(2010) - et al.
The Cardiovascular Health Study: design and rationale
Ann Epidemiol
(1991) - et al.
Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study
Ann Epidemiol
(1993) - et al.
Dyspnea in elderly family practice patientsOccurrence, severity, quality of life and mortality over an 8-year period
Fam Pract
(2006) - et al.
Dyspnea and 8-year mortality among elderly men and women: the PAQUID cohort study
Eur J Epidemiol
(2001) Chronic obstructive pulmonary disease outcome measurements
Proc Am Thorac Soc
(2005)- et al.
National Ambulatory Medical Care Survey: 1999 SummaryAdvanced Data from Vital and Health Statistics; No 322
(2001)
Risk factors and precipitants of long-term disability in community mobility
Ann Intern Med
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
N Engl J Med
Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study
J Gerontol A Biol Sci Med Sci
Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older
J Gerontol A Biol Sci Med Sci
Improvement in usual gait speed predicts better survival in older adults
J Am Geriatr Soc
Prognostic significance of potential frailty criteria
J Am Geriatr Soc
Risk due to inactivity in physically capable older adults
Am J Public Health
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea
Am J Respir Crit Care Med
Interpretative strategies for lung function tests
Eur Respir J
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?
Thorax
Aging
Proc Am Thorac Soc
Reference ranges for spirometry across all ages
Am J Respir Crit Care Med
Spirometry (LMS)
The need to change the method for defining mild airway obstruction
Eur Respir J
Predicted values: how should we use them?
Thorax
Lung volumes and forced ventilatory flows
Eur Respir J
The ratio of the forced expiratory volume in 1-second to forced vital capacity in establishing chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Cited by (0)
Funding: Dr Vaz Fragoso is a recipient of a Career Development Award from the Department of Veterans Affairs and an R03 award from the National Institute on Aging (R03AG037051). Dr Gill is the recipient of a National Institute on Aging Midcareer Investigator Award in Patient-Oriented Research (K24AG021507). Dr Concato is supported by the Department of Veterans Affairs Cooperative Studies Program.
Conflict of Interest: The study was conducted at the Veterans Affairs Clinical Epidemiology Research Center and the Yale Claude D. Pepper Older Americans Independence Center (P30AG2134). The investigators retained full independence in the conduct of this research. The Cardiovascular Health Study (CHS) was conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) of the United States in collaboration with the CHS Study Investigators. This manuscript was prepared using a limited access dataset obtained from the NHLBI and does not necessarily reflect the opinions or views of the CHS or the NHLBI.
Authorship: All authors had access to the data and played a role in writing this manuscript.